Tenaya Therapeutics TNYA
NASDAQ TNYA
$0.57 -0.04 (-6.28%)
At close: Oct 1, 2026 · 4:00 PM EDT

Tenaya Therapeutics (TNYA) Non Operating Income (2020 - 2026)

Updated

Tenaya Therapeutics' Non Operating Income was $695,000 in Q2 2026, down 13.0% from $799,000 a year earlier and down 12.4% from the prior quarter.

Analysis

Tenaya Therapeutics (TNYA) Non Operating Income (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, Tenaya Therapeutics' Non Operating Income was $2.75 million through Jun 30, 2026, down 18.3% year-over-year; for FY2025, it was $2.73 million, down 43.3% from FY2024.

  • Non Operating Income shows a five-year compound annual growth rate of 39.5% (FY2020 to FY2025).
  • In earlier years, Non Operating Income was $4.82 million in FY2024 (-32.2%), $7.11 million in FY2023 (+263.4%), $1.96 million in FY2022 and $85,000 in FY2021 (-83.6%).
  • Quarterly Non Operating Income has moved between $13,000 (Q4 2021) and $1.99 million (Q1 2023) over five years.
  • Compared with a year earlier, Non Operating Income was higher in 1 of the last eight quarters, with an average decline of 30.6%.
  • The best year-over-year quarter for Non Operating Income over five years was Q2 2023 (growth of 726.6%); the worst was Q3 2021 (a decline of 75.8%).
  • Per Business Quant data, TNYA's Non Operating Income in the three quarters before Q2 2026 was $793,000 (Q1 2026), $600,000 (Q4 2025) and $661,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -73.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 387.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Tenaya Therapeutics 134.54 Mn 134.54 Mn - 695,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 695,000.00
Mar 31, 2026 793,000.00
Dec 31, 2025 600,000.00
Sep 30, 2025 661,000.00
Jun 30, 2025 799,000.00
Mar 31, 2025 674,000.00
Dec 31, 2024 816,000.00
Sep 30, 2024 1.08 Mn
Jun 30, 2024 1.39 Mn
Mar 31, 2024 1.53 Mn
Dec 31, 2023 1.51 Mn
Sep 30, 2023 1.78 Mn
Jun 30, 2023 1.84 Mn
Mar 31, 2023 1.99 Mn
Dec 31, 2022 1.03 Mn
Sep 30, 2022 602,000.00
Jun 30, 2022 222,000.00
Mar 31, 2022 98,000.00
Dec 31, 2021 13,000.00
Sep 30, 2021 38,000.00
API Access

Tenaya Therapeutics Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=TNYA&period=max&api_key=YOUR_API_KEY